Literature DB >> 22355057

Targeting vascular endothelial growth factor in patients with squamous cell lung cancer.

Peter J Koo1, Daniel Morgensztern, Julie L Boyer, Roy S Herbst.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22355057     DOI: 10.1200/JCO.2011.40.4053

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab.

Authors:  Matthew D Hellmann; Jamie E Chaft; Valerie Rusch; Michelle S Ginsberg; David J Finley; Mark G Kris; Katharine A R Price; Christopher G Azzoli; Matthew G Fury; Gregory J Riely; Lee M Krug; Robert J Downey; Manjit S Bains; Camelia S Sima; Nabil Rizk; William D Travis; Naiyer A Rizvi; Paul K Paik
Journal:  Cancer Chemother Pharmacol       Date:  2013-06-28       Impact factor: 3.333

2.  Expression of Id-1 and VEGF in non-small cell lung cancer.

Authors:  Mee-Seon Kim; Tae-In Park; Yu-Mi Lee; Young-Min Jo; Sunzoo Kim
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

Review 3.  Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesis.

Authors:  Ji Wang; Chengchu Zhu
Journal:  Onco Targets Ther       Date:  2016-07-29       Impact factor: 4.147

4.  The role of long intergenic non-coding RNA for kinase activation (LINK-A) as an oncogene in non-small cell lung carcinoma.

Authors:  Parichehr Maleki; Seyed Javad Mowla; Mohammad Taheri; Soudeh Ghafouri-Fard; Jamshid Raheb
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

5.  EGFR biomarkers predict benefit from vandetanib in combination with docetaxel in a randomized phase III study of second-line treatment of patients with advanced non-small cell lung cancer.

Authors:  J V Heymach; S J Lockwood; R S Herbst; B E Johnson; A J Ryan
Journal:  Ann Oncol       Date:  2014-07-23       Impact factor: 32.976

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.